Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alsoKnownAs |
gptkb:BIX-01294
|
| gptkbp:CASNumber |
gptkb:202825-46-5
|
| gptkbp:hasBiologicalActivity |
G9a histone methyltransferase inhibitor
|
| gptkbp:hasMolecularFormula |
C21H12ClF3N2O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
202825-46-5
|
| gptkbp:IUPACName |
N-(4-(6-chloro-1,3-benzoxazol-2-yl)phenyl)-2-(trifluoromethyl)benzamide
|
| gptkbp:molecularWeight |
416.78 g/mol
|
| gptkbp:PubChem_CID |
11364421
CHEMBL180950 |
| gptkbp:usedIn |
epigenetics research
|
| gptkbp:bfsParent |
gptkb:mepolizumab
|
| gptkbp:bfsLayer |
7
|